October 17, 2007:
Low Doses of Red Wine Chemical May Fight Diabetes
By Ed Edelson
Περιοδικό
HealthDay Reporter
Chinese researchers have outlined the molecular chain of
activity that makes resveratrol, a chemical found in the
skin of red grapes and in red wine, a promising candidate
for treatment of diabetes and other conditions.
The study focused on how resveratrol improved the
sensitivity of mice to insulin, an effect that could lead to
new treatments for type 2 diabetes, in which human cells
lose their sensitivity to insulin.
And U.S. experts said the chemical's effect on a number
of different tissues could eventually lead to such
dreamed-of medications as an effective diet pill.
The study, by researchers at the Chinese Academy of
Sciences in Shanghai, showed that resveratrol activates an
enzyme called SIRT1. This enzyme, in turn, suppresses the
activity of a molecule called PTP1B, which ordinarily works
to decrease insulin activity. SIRT1 levels were reduced in
the animals' insulin-resistant cells. Increasing SIRT1
activity with resveratrol improved insulin sensitivity by
acting on PTP1B.
The study is published in the October issue of Cell
Metabolism.
"When you suppress PTP1B, insulin activity improves,"
said Young-Bum Kim, an assistant professor of medicine at
Beth Israel Deaconess Medical Center in Boston, one author
of an accompanying editorial in the journal.
"SIRT1 has a variety of functions in the body," Kim said.
"Now we can move on to other tissues, such as the brain. It
is possible that regulating the hypothalamus with SIRT1 can
prevent diet-induced obesity."
|
That is clearly a long-term goal, said Janice M.
Zabolotny, an instructor in medicine at Beth Israel
Deaconess, and the other author of the editorial. "But it
can make animals want less food and lower body weight," she
said. "By activating SIRT1, you could block the expression
of PTP1B and get the same hopeful benefit."
But clearly, "further studies are needed by other
researchers and on different tissues in animals," Zabolotny
said.
One striking finding was that much lower levels of
resveratrol than in previous trials were able to increase
the animals' sensitivity to insulin.
"This paper is different from previous reports in that
lower doses were effective," Zabolotny said. "The reason for
the difference is unclear."
A statement by Qiwei Zhai, lead author of the report,
recommended caution to resveratrol enthusiasts, noting that
those who have been drinking red wine might "think about
drinking less."
Previous studies had indicated that a human would have to
drink about 120 liters of red wine in a day to get the
benefit seen in animals. The new results reduce that amount
to a still-substantial three liters.
"An even better option may be to find other natural foods
enriched with resveratrol or foods supplemented with
resveratrol," Zhai said.
Ed Edelson
HealthDay Reporter

Προσθήκη:
17/10/2007
Τελευταία Ανανέωση:
17/10/2007
Για παλαιότερες δημοσιεύσεις κάντε κλικ
εδώ. |